Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity

Intra-tumour heterogeneity is a common molecular phenomenon in metastatic clear cell renal carcinoma (mRCC), representing the genetic complexity of a tumour with multiple metastatic sites. The present commentary discusses the observed phenomena of phenotypic intra-tumour heterogeneity in mRCC patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Stühler, Viktoria, Bedke, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141635/
https://www.ncbi.nlm.nih.gov/pubmed/27923360
http://dx.doi.org/10.1186/s12916-016-0754-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141635/
https://www.ncbi.nlm.nih.gov/pubmed/27923360
http://dx.doi.org/10.1186/s12916-016-0754-8

Ejemplares similares